Suppr超能文献

在用产肠毒素大肠杆菌菌株H10407和B7A经鼻攻击小鼠后测定其致病性和免疫反应。

Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A.

作者信息

Byrd Wyatt, Mog Steven R, Cassels Frederick J

机构信息

Department of Enteric Infections, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910-7500, USA.

出版信息

Infect Immun. 2003 Jan;71(1):13-21. doi: 10.1128/IAI.71.1.13-21.2003.

Abstract

The pathogenicity and immunogenicity induced in BALB/c mice by intranasal (i.n.) inoculation of enterotoxigenic Escherichia coli (ETEC) strains H10407 (O78:H11:CFA/I:LT(+):ST(+)) and B7A (O148:H28:CS6:LT(+):ST(+)) (two ETEC strains previously used in human challenge trials) were studied. The i.n. inoculation of BALB/c mice with large doses of ETEC strains H10407 and B7A caused illness and death. The H10407 strain was found to be consistently more virulent than the B7A strain. Following i.n. challenge with nonlethal doses of H10407 and B7A, the bacteria were cleared from the lungs of the mice at a steady rate over a 2-week period. Macrophages and neutrophils were observed in the alveoli and bronchioles, and lymphocytes were observed in the septa, around vessels, and in the pleura of the lungs in mice challenged with H10407 and B7A. In mice i.n. challenged with H10407, serum immunoglobulin G (IgG) and IgM antibodies were measured at high titers to the CFA/I and O78 lipopolysaccharide (LPS) antigens. In mice i.n. challenged with B7A, low serum IgG antibody titers were detected against CS6, and low serum IgG and IgM antibody titers were detected against O148 LPS. The serum IgG and IgM antibody titers against the heat-labile enterotoxin were equivalent in the H10407- and B7A-challenged mice. The CFA/I and O78 LPS antigens gave mixed T-helper cell 1-T-helper cell 2 (Th1-Th2) responses in which the Th2 response was greater than the Th1 response (i.e., stimulated primarily an antibody response). These studies indicate that the i.n. challenge of BALB/c mice with ETEC strains may provide a useful animal model to better understand the immunogenicity and pathogenicity of ETEC and its virulence determinants. This model may also be useful in providing selection criteria for vaccine candidates for use in primate and human trials.

摘要

研究了通过鼻内(i.n.)接种产肠毒素大肠杆菌(ETEC)菌株H10407(O78:H11:CFA/I:LT(+):ST(+))和B7A(O148:H28:CS6:LT(+):ST(+))(两种先前用于人体激发试验的ETEC菌株)在BALB/c小鼠中诱导的致病性和免疫原性。用大剂量ETEC菌株H10407和B7A鼻内接种BALB/c小鼠会导致疾病和死亡。发现H10407菌株的毒性始终比B7A菌株更强。用非致死剂量的H10407和B7A进行鼻内激发后,细菌在2周内以稳定的速率从小鼠肺部清除。在接种H10407和B7A的小鼠的肺泡和细支气管中观察到巨噬细胞和中性粒细胞,在肺间隔、血管周围和胸膜中观察到淋巴细胞。在用H10407进行鼻内激发的小鼠中,血清免疫球蛋白G(IgG)和IgM抗体对CFA/I和O78脂多糖(LPS)抗原的滴度较高。在用B7A进行鼻内激发的小鼠中,检测到针对CS6的血清IgG抗体滴度较低,针对O148 LPS的血清IgG和IgM抗体滴度较低。在接种H10407和B7A的小鼠中,针对不耐热肠毒素的血清IgG和IgM抗体滴度相当。CFA/I和O78 LPS抗原产生混合的辅助性T细胞1-辅助性T细胞2(Th1-Th2)反应,其中Th2反应大于Th1反应(即主要刺激抗体反应)。这些研究表明,用ETEC菌株对BALB/c小鼠进行鼻内激发可能提供一个有用的动物模型,以更好地了解ETEC的免疫原性和致病性及其毒力决定因素。该模型也可能有助于为用于灵长类动物和人体试验的候选疫苗提供选择标准。

相似文献

6
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
PLoS One. 2020 Dec 2;15(12):e0239888. doi: 10.1371/journal.pone.0239888. eCollection 2020.
7
Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic as a prophylactic against diarrhea.
Gut Microbes. 2020 Nov 9;12(1):1732852. doi: 10.1080/19490976.2020.1732852. Epub 2020 Mar 13.
10
Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
Clin Vaccine Immunol. 2011 Oct;18(10):1719-27. doi: 10.1128/CVI.05194-11. Epub 2011 Aug 18.

引用本文的文献

1
Heat-Labile Enterotoxin Decreases Macrophage Phagocytosis of Enterotoxigenic .
Microorganisms. 2023 Aug 21;11(8):2121. doi: 10.3390/microorganisms11082121.
2
Heat-Labile Toxin from Enterotoxigenic Causes Systemic Impairment in Zebrafish Model.
Toxins (Basel). 2021 Jun 12;13(6):419. doi: 10.3390/toxins13060419.
8
The molecular basis for control of ETEC enterotoxin expression in response to environment and host.
PLoS Pathog. 2015 Jan 8;11(1):e1004605. doi: 10.1371/journal.ppat.1004605. eCollection 2015 Jan.
10
A CssA, CssB and LTB chimeric protein induces protection against Enterotoxigenic Escherichia coli.
Braz J Infect Dis. 2014 May-Jun;18(3):308-14. doi: 10.1016/j.bjid.2013.07.012. Epub 2014 Jan 3.

本文引用的文献

1
Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.
Infect Immun. 2000 Dec;68(12):6624-32. doi: 10.1128/IAI.68.12.6624-6632.2000.
3
Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.
Infect Immun. 1999 Sep;67(9):4400-6. doi: 10.1128/IAI.67.9.4400-4406.1999.
4
Strategies for mucosal vaccine development.
Am J Trop Med Hyg. 1999 Apr;60(4 Suppl):35-45. doi: 10.4269/ajtmh.1999.60.35.
5
Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.
Infect Immun. 1999 May;67(5):2643-8. doi: 10.1128/IAI.67.5.2643-2648.1999.
9
Colonization factors of human enterotoxigenic Escherichia coli (ETEC).
Trends Microbiol. 1996 Nov;4(11):444-52. doi: 10.1016/0966-842x(96)10068-8.
10
Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.
Infect Immun. 1996 Dec;64(12):4933-9. doi: 10.1128/iai.64.12.4933-4939.1996.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验